Literature DB >> 16258163

Sensitive detection of polyalanine expansions in PHOX2B by polymerase chain reaction using bisulfite-converted DNA.

Hidekazu Horiuchi1, Ayako Sasaki, Motoki Osawa, Kazuki Kijima, Yukiko Ino, Ryoji Matoba, Kiyoshi Hayasaka.   

Abstract

Congenital central hypoventilation syndrome, also known as Ondine's curse, is characterized by idiopathic abnormal control of respiration during sleep. Recent studies indicate that a polyalanine expansion of PHOX2B is relevant to the pathogenesis of this disorder. However, it is difficult to detect the repeated tract because its high GC content inhibits conventional polymerase chain reaction (PCR) amplification. Here, we describe a bisulfite treatment for DNA in which uracil is obtained by deamination of unmethylated cytosine residues. Deamination of DNA permitted direct PCR amplification that yielded a product of 123 bp for the common 20-residue repetitive tract with replacement of C with T by sequencing. It settled allele dropouts accompanied by insufficient amplification of expanded alleles. The defined procedure dramatically improved detection of expansions to 9 of 10 congenital central hypoventilation syndrome patients examined in a previous study. The chemical conversion of DNA before PCR amplification facilitates effective detection of GC-rich polyalanine tracts.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16258163      PMCID: PMC1867560          DOI: 10.1016/S1525-1578(10)60598-3

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  16 in total

1.  PHOX2B genotype allows for prediction of tumor risk in congenital central hypoventilation syndrome.

Authors:  Delphine Trochet; Louise M O'Brien; David Gozal; Ha Trang; Agneta Nordenskjöld; Béatrice Laudier; Pär-Johan Svensson; Sabine Uhrig; Trevor Cole; Stephan Niemann; Arnold Munnich; Claude Gaultier; Stanislas Lyonnet; Jeanne Amiel
Journal:  Am J Hum Genet       Date:  2005-01-18       Impact factor: 11.025

2.  Evaluation of the fragile X (FRAXA) syndrome with methylation-sensitive PCR.

Authors:  A Weinhäusel; O A Haas
Journal:  Hum Genet       Date:  2001-06       Impact factor: 4.132

3.  Polyalanine expansion and frameshift mutations of the paired-like homeobox gene PHOX2B in congenital central hypoventilation syndrome.

Authors:  Jeanne Amiel; Béatrice Laudier; Tania Attié-Bitach; Ha Trang; Loïc de Pontual; Blanca Gener; Delphine Trochet; Heather Etchevers; Pierre Ray; Michel Simonneau; Michel Vekemans; Arnold Munnich; Claude Gaultier; Stanislas Lyonnet
Journal:  Nat Genet       Date:  2003-03-17       Impact factor: 38.330

4.  DNA deamination enables direct PCR amplification of the cystatin B (CSTB) gene-associated dodecamer repeat expansion in myoclonus epilepsy type Unverricht-Lundborg.

Authors:  Andreas Weinhaeusel; Michael A Morris; Stylianos E Antonarakis; Oskar A Haas
Journal:  Hum Mutat       Date:  2003-11       Impact factor: 4.878

5.  Molecular analysis of congenital central hypoventilation syndrome.

Authors:  Ayako Sasaki; Masayo Kanai; Kazuki Kijima; Kazuhiro Akaba; Motoya Hashimoto; Hisaya Hasegawa; Shinsuke Otaki; Takenobu Koizumi; Satoshi Kusuda; Youhei Ogawa; Keiji Tuchiya; Wakako Yamamoto; Tomohiko Nakamura; Kiyoshi Hayasaka
Journal:  Hum Genet       Date:  2003-10-18       Impact factor: 4.132

6.  Comparative analysis of amino acid repeats in rodents and humans.

Authors:  M Mar Albà; Roderic Guigó
Journal:  Genome Res       Date:  2004-04       Impact factor: 9.043

7.  Idiopathic congenital central hypoventilation syndrome: analysis of genes pertinent to early autonomic nervous system embryologic development and identification of mutations in PHOX2b.

Authors:  Debra E Weese-Mayer; Elizabeth M Berry-Kravis; Lili Zhou; Brion S Maher; Jean M Silvestri; Mark E Curran; Mary L Marazita
Journal:  Am J Med Genet A       Date:  2003-12-15       Impact factor: 2.802

8.  Sudden infant death syndrome is not associated with the mutation of PHOX2B gene, a major causative gene of congenital central hypoventilation syndrome.

Authors:  Kazuki Kijima; Ayako Sasaki; Takao Niki; Kazuo Umetsu; Motoki Osawa; Ryoji Matoba; Kiyoshi Hayasaka
Journal:  Tohoku J Exp Med       Date:  2004-05       Impact factor: 1.848

Review 9.  Alanine tracts: the expanding story of human illness and trinucleotide repeats.

Authors:  Lucia Y Brown; Stephen A Brown
Journal:  Trends Genet       Date:  2004-01       Impact factor: 11.639

10.  PHOX2B mutations and polyalanine expansions correlate with the severity of the respiratory phenotype and associated symptoms in both congenital and late onset Central Hypoventilation syndrome.

Authors:  I Matera; T Bachetti; F Puppo; M Di Duca; F Morandi; G M Casiraghi; M R Cilio; R Hennekam; R Hofstra; J G Schöber; R Ravazzolo; G Ottonello; I Ceccherini
Journal:  J Med Genet       Date:  2004-05       Impact factor: 6.318

View more
  4 in total

1.  Genotype-phenotype relationship in Japanese patients with congenital central hypoventilation syndrome.

Authors:  Tomoyuki Shimokaze; Ayako Sasaki; Toru Meguro; Hisaya Hasegawa; Yuka Hiraku; Tetsushi Yoshikawa; Yumiko Kishikawa; Kiyoshi Hayasaka
Journal:  J Hum Genet       Date:  2015-06-11       Impact factor: 3.172

2.  De novo polyalanine expansion of PHOX2B in congenital central hypoventilation syndrome: unequal sister chromatid exchange during paternal gametogenesis.

Authors:  Hiroko Arai; Tesshu Otagiri; Ayako Sasaki; Taeko Hashimoto; Kazuo Umetsu; Katsushi Tokunaga; Kiyoshi Hayasaka
Journal:  J Hum Genet       Date:  2007-10-11       Impact factor: 3.172

3.  Betaine, dimethyl sulfoxide, and 7-deaza-dGTP, a powerful mixture for amplification of GC-rich DNA sequences.

Authors:  Marco Musso; Renata Bocciardi; Sara Parodi; Roberto Ravazzolo; Isabella Ceccherini
Journal:  J Mol Diagn       Date:  2006-11       Impact factor: 5.568

4.  Non-polyalanine repeat mutation in PHOX2B is detected in autopsy cases of sudden unexpected infant death.

Authors:  Atsushi Ueda; Motoki Osawa; Haruaki Naito; Eriko Ochiai; Yu Kakimoto
Journal:  PLoS One       Date:  2022-04-29       Impact factor: 3.752

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.